Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

41.35
+0.36060.88%
Post-market: 41.350.00000.00%16:10 EDT
Volume:77.34K
Turnover:3.18M
Market Cap:205.93M
PE:- -
High:41.43
Open:41.00
Low:40.43
Close:40.99
52wk High:47.00
52wk Low:29.28
Shares:4.98M
Float Shares:4.98M
Volume Ratio:2.02
T/O Rate:1.55%
Dividend:0.02
Dividend Rate:0.05%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Twist Bioscience Corporation - to Provide Antibody Characterization Data Services for Lilly Tunelab

THOMSON REUTERS
·
Sep 16

Circle Pharma: Financing Led by Column Group, Participation from Nextech Invest, Ra Capital Management, Strategic Investment from Eli Lilly and Co

THOMSON REUTERS
·
Sep 16

Revolution Medicines gets orphan designation for pancreatic cancer treatment

TIPRANKS
·
Sep 16

Thatch Raises $108 Million at $1 Billion Valuation

Reuters
·
Sep 16

Thatch: Funding & Participation from the General Partnership, General Catalyst, Andreessen Horowitz, ADP Ventures, Eli Lilly & Others

THOMSON REUTERS
·
Sep 16

U.S. Stocks on the MOVE-Forgent Power, Vera Bradley, Wells Fargo

Reuters
·
Sep 16

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Sep 15

Eli Lilly Stock (LLY) Gets New Buy Rating as Weight-Loss Drug Sales Accelerate

TIPRANKS
·
Sep 15

Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to Buy

Dow Jones
·
Sep 15

Legend Biotech Shares Down 1.8%; Co Appoints Ingrid Zhang as CEO

THOMSON REUTERS
·
Sep 15

Legend Biotech Taps Novartis Veteran Zhang as CEO

Reuters
·
Sep 15

Cogent Biosciences reports FDA acceptance of bezuclastinib new drug application

TIPRANKS
·
Sep 15

U.S. Stocks on the MOVE-Eli Lilly, Waystar, Sysco

Reuters
·
Sep 15

Legend Biotech Corporation - Alan Bash to Resume Role as President, Carvykti

THOMSON REUTERS
·
Sep 15

Legend Biotech Corporation - Appoints Ingrid Zhang as CEO Effective September 15, 2026

THOMSON REUTERS
·
Sep 15

Cogent Biosciences, - FDA States no Advisory Committee Planned and no Review Issues Identified

THOMSON REUTERS
·
Sep 15

Cogent Biosciences Announces FDA Acceptance of New Drug Application (Nda) for Bezuclastinib in Patients with Advanced Systemic Mastocytosis (Advsm)

THOMSON REUTERS
·
Sep 15

Cogent Biosciences, - FDA Accepts Nda for Bezuclastinib in Advsm with Pdufa Date June 29, 2027

THOMSON REUTERS
·
Sep 15

Press Release: Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer

Dow Jones
·
Sep 15

Legend Biotech is Expected to Name Ingrid Zhang as Its New Chief Executive - WSJ

THOMSON REUTERS
·
Sep 15